Ahead Therapeutics participated in the ICONAN conference 2019 (https://www.controlledreleasesociety.org/events/2019-international-conference-nanomedicine-and-nanobiotechnology-iconan).

Nanomedicine and Nanobiotechnology have tremendous potential for tomorrow’s patient care in a broad variety of disease management, and numerous theoretical concepts are currently translated into preclinical and clinical studies. The fourth edition of the ICONAN conference brought together high-profile plenary speakers and world-class researchers who have successfully developed and translated nanomedicines over the last decades

.